Adaptive radiotherapy for head and neck cancer

References

• Barker JL Jr., Garden AS, Ang KK, et al. Quantification of volumetric and geometric changes occurring during fractionated radiotherapy for head-and-neck cancer using an integrated CT/linear accelerator system. Int J Radiat Oncol Biol Phys. 2004;59:960–970.
   PubMed Web of Science ®Google Scholar
• Nishi T, Nishimura Y, Shibata T, et al. Volume and dosimetric changes and initial clinical experience of a two-step adaptive intensity modulated radiation therapy (IMRT) scheme for head and neck cancer. Radiother Oncol. 2013;106:85–89.
   PubMed Web of Science ®Google Scholar
• Duma MN, Kampfer S, Schuster T, et al. Adaptive radiotherapy for soft tissue changes during helical tomotherapy for head and neck cancer. Strahlenther Onkol. 2012;188:243–247.
   PubMed Web of Science ®Google Scholar
• Gregoire V, Jeraj R, Lee JA, et al. Radiotherapy for head and neck tumours in 2012 and beyond: conformal, tailored, and adaptive? Lancet Oncol. 2012;13:e292–e300.
   PubMed Web of Science ®Google Scholar
• Schwartz DL. Current progress in adaptive radiation therapy for head and neck cancer. Curr Oncol Rep. 2012;14:139–147.
   PubMed Web of Science ®Google Scholar
• Zeidan OA, Langen KM, Meeks SL, et al. Evaluation of image-guidance protocols in the treatment of head and neck cancers. Int J Radiat Oncol Biol Phys. 2007;67:670–677.
   PubMed Web of Science ®Google Scholar
• Den RB, Doemer A, Kubicek G, et al. Daily image guidance with cone-beam computed tomography for head-and-neck cancer intensity-modulated radiotherapy: a prospective study. Int J Radiat Oncol Biol Phys. 2010;76:1353–1359.
   PubMed Web of Science ®Google Scholar
• Djordjevic M, Sjoholm E, Tullgren O, et al. Assessment of residual setup errors for anatomical sub-structures in image-guided head-and-neck cancer radiotherapy. Acta Oncol. 2014;53:646–653.
   PubMed Web of Science ®Google Scholar
• van Kranen S, van Beek S, Mencarelli A, et al. Correction strategies to manage deformations in head-and-neck radiotherapy. Radiother Oncol. 2010;94:199–205.
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535.
   PubMed Web of Science ®Google Scholar
• Capelle L, Mackenzie M, Field C, et al. Adaptive radiotherapy using helical tomotherapy for head and neck cancer in definitive and postoperative settings: initial results. Clin Oncol (R Coll Radiol). 2012;24:208–215.
   PubMed Web of Science ®Google Scholar
• Castelli J, Simon A, Louvel G, et al. Impact of head and neck cancer adaptive radiotherapy to spare the parotid glands and decrease the risk of xerostomia. Radiat Oncol. 2015;10:6.
   PubMed Web of Science ®Google Scholar
• Dewan A, Sharma S, Dewan A, et al. Impact of adaptive radiotherapy on locally advanced head and neck cancer - a dosimetric and volumetric study. Asian Pac J Cancer Prev. 2016;17:985–992.
   PubMedGoogle Scholar
• Jensen AD, Nill S, Huber PE, et al. A clinical concept for interfractional adaptive radiation therapy in the treatment of head and neck cancer. Int J Radiat Oncol Biol Phys. 2012;82:590–596.
   PubMed Web of Science ®Google Scholar
• Olteanu LA, Berwouts D, Madani I, et al. Comparative dosimetry of three-phase adaptive and non-adaptive dose-painting IMRT for head-and-neck cancer. Radiother Oncol. 2014;111:348–353.
   PubMed Web of Science ®Google Scholar
• Schwartz DL, Garden AS, Thomas J, et al. Adaptive radiotherapy for head-and-neck cancer: initial clinical outcomes from a prospective trial. Int J Radiat Oncol Biol Phys. 2012;83:986–993.
   PubMed Web of Science ®Google Scholar
• Zhao L, Wan Q, Zhou Y, et al. The role of replanning in fractionated intensity modulated radiotherapy for nasopharyngeal carcinoma. Radiother Oncol. 2011;98:23–27.
   PubMed Web of Science ®Google Scholar
• Kataria T, Gupta D, Goyal S, et al. Clinical outcomes of adaptive radiotherapy in head and neck cancers. Br J Radiol. 2016;89:20160085.
   PubMed Web of Science ®Google Scholar
• Yang H, Hu W, Wang W, et al. Replanning during intensity modulated radiation therapy improved quality of life in patients with nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2013;85:e47–e54.
   PubMed Web of Science ®Google Scholar
• Chen AM, Daly ME, Cui J, et al. Clinical outcomes among patients with head and neck cancer treated by intensity-modulated radiotherapy with and without adaptive replanning. Head Neck. 2014;36:1541–1546.
   PubMed Web of Science ®Google Scholar
• Ahn PH, Chen CC, Ahn AI, et al. Adaptive planning in intensity-modulated radiation therapy for head and neck cancers: single-institution experience and clinical implications. Int J Radiat Oncol Biol Phys. 2011;80:677–685.
   PubMed Web of Science ®Google Scholar
• Beltran M, Ramos M, Rovira JJ, et al. Dose variations in tumor volumes and organs at risk during IMRT for head-and-neck cancer. J Appl Clin Med Phys. 2012;13:101–111.
   Web of Science ®Google Scholar
• Berwouts D, Olteanu LA, Duprez F, et al. Three-phase adaptive dose-painting-by-numbers for head-and-neck cancer: initial results of the phase I clinical trial. Radiother Oncol. 2013;107:310–316.
   PubMed Web of Science ®Google Scholar
• Ho KF, Marchant T, Moore C, et al. Monitoring dosimetric impact of weight loss with kilovoltage (kV) cone beam CT (CBCT) during parotid-sparing IMRT and concurrent chemotherapy. Int J Radiat Oncol Biol Phys. 2012;82:e375–e382.
   PubMed Web of Science ®Google Scholar
• Hunter KU, Fernandes LL, Vineberg KA, et al. Parotid glands dose-effect relationships based on their actually delivered doses: implications for adaptive replanning in radiation therapy of head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2013;87:676–682.
   PubMed Web of Science ®Google Scholar
• Marzi S, Pinnarò P, D’Alessio D, et al. Anatomical and dose changes of gross tumour volume and parotid glands for head and neck cancer patients during intensity-modulated radiotherapy: effect on the probability of xerostomia incidence. Clin Oncol (R Coll Radiol). 2012;24:e54–e62.
   PubMed Web of Science ®Google Scholar
• O’Daniel JC, Garden AS, Schwartz DL, et al. Parotid gland dose in intensity-modulated radiotherapy for head and neck cancer: is what you plan what you get? Int J Radiat Oncol Biol Phys. 2007;69:1290–1296.
   PubMed Web of Science ®Google Scholar
• Orban de Xivry J, Castadot P, Janssens G, et al. Evaluation of the radiobiological impact of anatomic modifications during radiation therapy for head and neck cancer: can we simply summate the dose? Radiother Oncol. 2010;96:131–138.
   PubMed Web of Science ®Google Scholar
• Robar JL, Day A, Clancey J, et al. Spatial and dosimetric variability of organs at risk in head-and-neck intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys. 2007;68:1121–1130.
   PubMed Web of Science ®Google Scholar
• Yip C, Thomas C, Michaelidou A, et al. Co-registration of cone beam CT and planning CT in head and neck IMRT dose estimation: a feasible adaptive radiotherapy strategy. Br J Radiol. 2014;87:20130532.
   PubMed Web of Science ®Google Scholar
• Schwartz DL, Garden AS, Shah SJ, et al. Adaptive radiotherapy for head and neck cancer-dosimetric results from a prospective clinical trial. Radiother Oncol. 2013;106:80–84.
   PubMed Web of Science ®Google Scholar
• Wu Q, Chi Y, Chen PY, et al. Adaptive replanning strategies accounting for shrinkage in head and neck IMRT. Int J Radiat Oncol Biol Phys. 2009;75:924–932.
   PubMed Web of Science ®Google Scholar
• Zhang P, Simon A, Rigaud B, et al. Optimal adaptive IMRT strategy to spare the parotid glands in oropharyngeal cancer. Radiother Oncol. 2016;120:41–47.
   PubMed Web of Science ®Google Scholar
• Bhide SA, Davies M, Burke K, et al. Weekly volume and dosimetric changes during chemoradiotherapy with intensity-modulated radiation therapy for head and neck cancer: a prospective observational study. Int J Radiat Oncol Biol Phys. 2010;76:1360–1368.
   PubMed Web of Science ®Google Scholar
• Height R, Khoo V, Lawford C, et al. The dosimetric consequences of anatomic changes in head and neck radiotherapy patients. J Med Imaging Radiat Oncol. 2010;54:497–504.
   PubMed Web of Science ®Google Scholar
• Chen C, Fei Z, Chen L, et al. Will weight loss cause significant dosimetric changes of target volumes and organs at risk in nasopharyngeal carcinoma treated with intensity-modulated radiation therapy? Med Dosim. 2014;39:34–37.
   PubMed Web of Science ®Google Scholar
• Hansen EK, Bucci MK, Quivey JM, et al. Repeat CT imaging and replanning during the course of IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2006;64:355–362.
   PubMed Web of Science ®Google Scholar
• Lai YL, Yang SN, Liang JA, et al. Impact of body-mass factors on setup displacement in patients with head and neck cancer treated with radiotherapy using daily on-line image guidance. Radiat Oncol. 2014;9:19.
   PubMed Web of Science ®Google Scholar
• Nutting CM, Morden JP, Harrington KJ, et al. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol. 2011;12:127–136.
   PubMed Web of Science ®Google Scholar
• Bourhis J, Sire C, Graff P, et al. Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma (GORTEC 99-02): an open-label phase 3 randomised trial. Lancet Oncol. 2012;13:145–153.
   PubMed Web of Science ®Google Scholar
• Kataria T, Gupta D, Bisht SS, et al. Chemoradiation in elderly patients with head and neck cancers: a single institution experience. Am J Otolaryngol. 2015;36:117–121.
   PubMed Web of Science ®Google Scholar
• Kam MK, Leung SF, Zee B, et al. Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients. J Clin Oncol. 2007;25:4873–4879.
   PubMed Web of Science ®Google Scholar
• Pow EH, Kwong DL, McMillan AS, et al. Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial. Int J Radiat Oncol Biol Phys. 2006;66:981–991.
   PubMed Web of Science ®Google Scholar
• Feng FY, Kim HM, Lyden TH, et al. Intensity-modulated chemoradiotherapy aiming to reduce dysphagia in patients with oropharyngeal cancer: clinical and functional results. J Clin Oncol. 2010;28:2732–2738.
   PubMed Web of Science ®Google Scholar
• Chajon E, Lafond C, Louvel G, et al. Salivary gland-sparing other than parotid-sparing in definitive head-and-neck intensity-modulated radiotherapy does not seem to jeopardize local control. Radiat Oncol. 2013;8:132.
   PubMed Web of Science ®Google Scholar
• Bjordal K, de Graeff A, Fayers PM, et al. A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients. EORTC Quality of Life Group. Eur J Cancer (Oxford, England: 1990). 2000;36:1796–1807.
   PubMed Web of Science ®Google Scholar
• Castelli J, Simon A, Rigaud B, et al. A Nomogram to predict parotid gland overdose in head and neck IMRT. Radiat Oncol. 2016;11:79.
   PubMed Web of Science ®Google Scholar
• Deasy JO, Moiseenko V, Marks L, et al. Radiotherapy dose-volume effects on salivary gland function. Int J Radiat Oncol Biol Phys. 2010;76:S58–S63.
   PubMed Web of Science ®Google Scholar
• Lyman JT. Complication probability as assessed from dose-volume histograms. Radiat Res Suppl. 1985;8:S13–S19.
   PubMedGoogle Scholar
• Dijkema T, Raaijmakers CP, Ten Haken RK, et al. Parotid gland function after radiotherapy: the combined michigan and utrecht experience. Int J Radiat Oncol Biol Phys. 2010;78:449–453.
   PubMed Web of Science ®Google Scholar
• Fitzpatrick JM, Hill DL, Shyr Y, et al. Visual assessment of the accuracy of retrospective registration of MR and CT images of the brain. IEEE Trans Med Imaging. 1998;17:571–585.
   PubMed Web of Science ®Google Scholar
• Dice LR. Measures of the amount of ecologic association between species. Ecology.1945;26:297–302.
   Web of Science ®Google Scholar
• Graves YJ, Smith AA, McIlvena D, et al. A deformable head and neck phantom with in-vivo dosimetry for adaptive radiotherapy quality assurance. Med Phys. 2015;42:1490–1497.
   PubMed Web of Science ®Google Scholar
• Kirby N, Chuang C, Pouliot J. A two-dimensional deformable phantom for quantitatively verifying deformation algorithms. Med Phys. 2011;38:4583–4586.
   PubMed Web of Science ®Google Scholar
• Tsuji SY, Hwang A, Weinberg V, et al. Dosimetric evaluation of automatic segmentation for adaptive IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2010;77:707–714.
   PubMed Web of Science ®Google Scholar
• Lim JY, Leech M. Use of auto-segmentation in the delineation of target volumes and organs at risk in head and neck. Acta Oncol. 2016;55:799–806.
   PubMed Web of Science ®Google Scholar
• Brock KK, Mutic S, McNutt TR, et al. Use of image registration and fusion algorithms and techniques in radiotherapy: Report of the AAPM Radiation Therapy Committee Task Group No. 132. Med Phys. 2017;44:e43–e76.
   PubMed Web of Science ®Google Scholar
• Hvid CA, Elstrøm UV, Jensen K, et al. Cone-beam computed tomography (CBCT) for adaptive image guided head and neck radiation therapy. Acta Oncol. 2018;57(4):552–556.
   Google Scholar
• Brown E, Owen R, Harden F, et al. Predicting the need for adaptive radiotherapy in head and neck cancer. Radiother Oncol. 2015;116:57–63.
   PubMed Web of Science ®Google Scholar
• Surucu M, Shah KK, Mescioglu I, et al. Decision trees predicting tumor shrinkage for head and neck cancer: implications for adaptive radiotherapy. Technol Cancer Res Treat. 2016;15:139–145.
   PubMed Web of Science ®Google Scholar
• Pugachev A, Ruan S, Carlin S, et al. Dependence of FDG uptake on tumor microenvironment. Int J Radiat Oncol Biol Phys. 2005;62:545–553.
   PubMed Web of Science ®Google Scholar
• Due AK, Vogelius IR, Aznar MC, et al. Recurrences after intensity modulated radiotherapy for head and neck squamous cell carcinoma more likely to originate from regions with high baseline [18F]-FDG uptake. Radiother Oncol. 2014;111:360–365.
   PubMed Web of Science ®Google Scholar
• Madani I, Duthoy W, Derie C, et al. Positron emission tomography-guided, focal-dose escalation using intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys. 2007;68:126–135.
   PubMed Web of Science ®Google Scholar
• Vanderstraeten B, De Gersem W, Duthoy W, et al. Implementation of biologically conformal radiation therapy (BCRT) in an algorithmic segmentation-based inverse planning approach. Phys Med Biol. 2006;51:N277–N286.
   PubMed Web of Science ®Google Scholar
• Geets X, Tomsej M, Lee JA, et al. Adaptive biological image-guided IMRT with anatomic and functional imaging in pharyngo-laryngeal tumors: impact on target volume delineation and dose distribution using helical tomotherapy. Radiother Oncol. 2007;85:105–115.
   PubMed Web of Science ®Google Scholar
• Differding S, Sterpin E, Janssens G, et al. Methodology for adaptive and robust FDG-PET escalated dose painting by numbers in head and neck tumors. Acta Oncol. 2016;55:217–225.
   PubMed Web of Science ®Google Scholar
• Duprez F, De Neve W, De Gersem W, et al. Adaptive dose painting by numbers for head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2011;80:1045–1055.
   PubMed Web of Science ®Google Scholar
• Rosen BS, Hawkins PG, Polan DF, et al. Early changes in serial CBCT-measured parotid gland biomarkers predict chronic xerostomia after head and neck radiotherapy. Int J Radiat Oncol Biol Phys. 2018;9. pii: S0360-3016(18)31049-6. doi: 10.1016/j.ijrobp.2018.06.048.
   Google Scholar
• Gros SA, Xu W, Roeske JC, et al. A novel surrogate to identify anatomical changes during radiotherapy of head and neck cancer patients. Med Phys. 2017;44:924–934.
   PubMed Web of Science ®Google Scholar
• Piron O, Varfalvy N, Archambault L. Establishing action threshold for change in patient anatomy using EPID gamma analysis and PTV coverage for head and neck radiotherapy treatment. Med Phys. 2018;13. doi:10.1002/mp.13045 [epub ahead of print].
   Google Scholar
• Raaymakers BW, Jurgenliemk-Schulz IM, Bol GH, et al. First patients treated with a 1.5 T MRI-Linac: clinical proof of concept of a high-precision, high-field MRI guided radiotherapy treatment. Phys Med Biol. 2017;62:L41–L50.
   PubMed Web of Science ®Google Scholar
• Lagendijk JJ, Raaymakers BW, van Vulpen M. The magnetic resonance imaging-linac system. Semin Radiat Oncol. 2014;24:207–209.
   PubMed Web of Science ®Google Scholar
• Lagendijk JJ, van Vulpen M, Raaymakers BW. The development of the MRI linac system for online MRI-guided radiotherapy: a clinical update. J Intern Med. 2016;280:203–208.
   PubMed Web of Science ®Google Scholar
• Kupelian P, Sonke JJ. Magnetic resonance-guided adaptive radiotherapy: a solution to the future. Semin Radiat Oncol. 2014;24:227–232.
   PubMed Web of Science ®Google Scholar